Breaking
Saturday, June 20, 2026

FDA News

🇺🇸 FDA Page 23

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 265–276 of 391 articles

Medium impact AnalysisMay 21, 2026

Dark Times Ahead at the FDA: Implications for Pharma

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

Impact of FDA Turnover on Rare Disease Drug Development

FDA · rare disease · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

ImmunityBio's Anktiva Expansion: FDA Decision Date Insights

FDA · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 21, 2026

New FDA Guidance on ENDS and Nicotine Pouch Products

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

Atara Bounces Back with FDA Approval in Oncology

FDA · oncology · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 21, 2026

FDA Alert: Key Updates on Pulmonology Drug Approvals

FDA · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 21, 2026

FDA to Consider Lifting Restrictions on Compounded Peptides

FDA · 3 min

Dr. Sarah Mitchell
High impact AnalysisMay 20, 2026

Biotech Investors' Mood and FDA Insights: What You Need to Know

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 20, 2026

FDA's Bayesian Methodology: A Game Changer for Drug Development

FDA · 3 min

Dr. Sarah Mitchell
High impact AnalysisMay 20, 2026

FDA's Unreleased Covid Vaccine Deaths Report: What You Need to Know

FDA · COVID-19 · 2 min

Dr. Sarah Mitchell
High impact AnalysisMay 19, 2026

FDA Approves AstraZeneca’s Baxdrostat for Hypertension

FDA · hypertension · 3 min

Dr. Sarah Mitchell
High impact AnalysisMay 19, 2026

U.S. Bans Entry from Ebola-Affected Countries Amid Patient Identification

FDA · Ebola · 3 min

Dr. Sarah Mitchell